Administration of fenoldopam in critically ill small animal patients with acute kidney injury: 28 dogs and 34 cats (2008–2012)
- 8 April 2015
- journal article
- research article
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 25 (3) , 396-404
Abstract
Objective: To describe the clinical features and outcomes of critically ill dogs and cats with acute kidney injury (AKI) receiving fenoldopam infusions compared to patients with AKI that did not receive fenoldopam.Design: Retrospective clinical study from May 1, 2008 until June 1, 2012.Setting: Private emergency and specialty referral hospital.Animals: Client‐owned dogs (28) and cats (34) with AKI that received fenoldopam compared with similar patients with AKI (30 dogs and 30 cats) that did not.Interventions: None.Measurements and Main Results: The medical records of 62 critically ill dogs and cats with AKI that received fenoldopam were reviewed. Presenting clinical signs, physical examination findings, and primary and secondary disease processes were identified in all patients. The mean number of days on fenoldopam was 1.5 days (range 0.3–4.0 days) for dogs and 1.9 days (range 1.0–4.0 days) for cats. Eleven of 28 (39%) dogs survived to discharge and 13 of 34 (38%) of the cats survived to discharge. Of the animals in the group receiving fenoldopam that died, the majority (84%) were euthanized. Potential adverse reactions were evaluated, with hypotension being the most commonly encountered adverse effect (7% of fenoldopam group [FG] dogs and 23% of FG cats). When compared with patients with AKI that did not receive fenoldopam, no significant differences were found between the groups with regards to survival, length of hospital stay, adverse effects, or changes in creatinine, BUN, or sodium concentrations except that patients receiving fenoldopam were significantly more likely to have received other renally active medications.Conclusions: In this study of patients with AKI, fenoldopam administration at 0.8 μg/kg/min in dogs and 0.5 μg/kg/min in cats appeared relatively safe but was not associated with improvement in survival to discharge, length of hospital stay, or improvement in renal biochemical parameters when compared to patients with AKI not receiving fenoldopam.Keywords
This publication has 32 references indexed in Scilit:
- Prognostic Factors and a Prognostic Index for Cats with Acute Kidney InjuryJournal of Veterinary Internal Medicine, 2012
- Characterization of acute kidney injury in hospitalized dogs and evaluation of a veterinary acute kidney injury staging systemJournal of Veterinary Emergency and Critical Care, 2011
- Preliminary pharmacokinetics and cardiovascular effects of fenoldopam continuous rate infusion in six healthy dogsJournal of Veterinary Pharmacology and Therapeutics, 2011
- Fenoldopam in Critically Ill Patients with Early Renal Dysfunction. A Crossover StudyCardiovascular Therapeutics, 2010
- An update on cardiovascular adrenergic receptor physiology and potential pharmacological applications in veterinary critical careJournal of Veterinary Emergency and Critical Care, 2008
- Calcium channel blocker toxicityJournal of Veterinary Emergency and Critical Care, 2008
- Acute kidney injury in the intensive care unit according to RIFLE*Critical Care Medicine, 2007
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injuryCritical Care, 2007
- A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients*Critical Care Medicine, 2006
- Dopamine and new dopamine analogs: Receptors and clinical applicationsJournal of Clinical Anesthesia, 1988